We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
-3.07%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$46.8B
AUM Growth
+$933M
Cap. Flow
+$2.08B
Cap. Flow %
4.45%
Top 10 Hldgs %
8.13%
Holding
3,617
New
458
Increased
1,225
Reduced
1,321
Closed
452

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$255M
2
PGR icon
Progressive
PGR
+$244M
3
V icon
Visa
V
+$238M
4
LRCX icon
Lam Research
LRCX
+$201M
5
ELV icon
Elevance Health
ELV
+$190M

Sector Composition

Rank Sector Weight
1 Technology 17.88%
2 Healthcare 13.28%
3 Financials 10.32%
4 Industrials 9.79%
5 Consumer Discretionary 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MVIS icon
2651
Microvision
MVIS
$52M
$302K ﹤0.01%
16,211
+2,618
+19% +$54.7K
SIXS icon
2652
ETC 6 Meridian Small Cap Equity ETF
SIXS
$146M
$300K ﹤0.01%
+6,400
New +$311K
KOD icon
2653
Kodiak Sciences
KOD
$2.34B
$299K ﹤0.01%
106,664
+57,258
+116% +$311K
INFU icon
2654
InfuSystem Holdings
INFU
$238M
$297K ﹤0.01%
55,287
+19,035
+53% +$139K
EOSE icon
2655
Eos Energy Enterprises
EOSE
$1.26B
$296K ﹤0.01%
+78,389
New +$382K
FIP icon
2656
FTAI Infrastructure
FIP
$443M
$295K ﹤0.01%
65,211
-214,816
-77% -$1.34M
LGND icon
2657
Ligand Pharmaceuticals
LGND
$5.59B
$294K ﹤0.01%
2,800
-207
-7% -$23.4K
LAD icon
2658
Lithia Motors
LAD
$8.1B
$294K ﹤0.01%
1,000
KOPN icon
2659
Kopin
KOPN
$881M
$293K ﹤0.01%
314,363
-247,674
-44% -$364K
HPK icon
2660
HighPeak Energy
HPK
$1.03B
$292K ﹤0.01%
23,091
-35,786
-61% -$481K
SGC icon
2661
Superior Group of Companies
SGC
$203M
$291K ﹤0.01%
26,633
+2,980
+13% +$41.9K
FFLG icon
2662
Fidelity Fundamental Large Cap Growth ETF
FFLG
$606M
$290K ﹤0.01%
13,100
-59,000
-82% -$1.46M
CKPT
2663
DELISTED
Checkpoint Therapeutics
CKPT
$290K ﹤0.01%
71,727
-1,305
-2% -$4.35K
EVC icon
2664
Entravision Communication
EVC
$748M
$289K ﹤0.01%
137,632
-4,481
-3% -$9.8K
CARS icon
2665
Cars.com
CARS
$662M
$287K ﹤0.01%
25,502
-108,976
-81% -$1.66M
ESOA icon
2666
Energy Services of America
ESOA
$215M
$287K ﹤0.01%
30,346
+10,146
+50% +$111K
RBCAA icon
2667
Republic Bancorp
RBCAA
$1.86B
$286K ﹤0.01%
4,476
+894
+25% +$59.3K
NRC icon
2668
NRC Health Common Stock
NRC
$485M
$285K ﹤0.01%
22,265
-19,426
-47% -$312K
SLV icon
2669
iShares Silver Trust
SLV
$33.5B
$285K ﹤0.01%
+9,194
New +$267K
MZTI
2670
The Marzetti Company
MZTI
$3.17B
$285K ﹤0.01%
+1,626
New +$293K
XRT icon
2671
State Street SPDR S&P Retail ETF
XRT
$329M
$283K ﹤0.01%
+4,100
New +$310K
MTLS
2672
Materialise
MTLS
$387M
$283K ﹤0.01%
57,569
-23,701
-29% -$163K
WCC
2673
WESCO International
WCC
$16.4B
$282K ﹤0.01%
1,813
-209
-10% -$37.4K
VTGN icon
2674
VistaGen Therapeutics
VTGN
$10.8M
$281K ﹤0.01%
112,507
-24,827
-18% -$70.3K
XTN icon
2675
State Street SPDR S&P Transportation ETF
XTN
$371M
$281K ﹤0.01%
3,800
-35,200
-90% -$2.96M

Similar funds

John Overdeck's Q1 2025 Portfolio in Review

As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.

  • John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
  • John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
  • John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
  • John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
  • John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
  • John Overdeck opened 458 new positions and closed 452 in Q1 2025.
  • John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.